📱 Now on iPhone — live scores, valuations & alerts on the go
Download iPhone App

Park Ha Biological Technology Co., Ltd. (BYAH)

Materials Inconclusive inconclusive mixed
$2.21
Updated: 2026-10-25

As of October 25, 2026, TradeApes rates Park Ha Biological Technology Co., Ltd. (BYAH) 58 out of 100 (Mixed); valuation verdict: Inconclusive.

58
TradeApes Score
Financial Strength
55 Mixed
Operating Trend
50 Mixed
Relative Value
65 Fair value
Capital Allocation
50 Mixed
Risk Management
80 Strong

BYAH is a type of company our standard valuation methods don't fit, so we don't publish a fair value for it.

Key Findings
What's working
  • + High FCF yield — above 7%, strong cash return relative to price paid
  • + Strong liquidity — current assets more than 2× current liabilities
AI-written analysis
The full Park Ha Biological Technology Co., Ltd. (BYAH) analysis
Why the model reads BYAH as inconclusive, the methods that voted, and what would change the verdict. Written from the same filings as the score above. How these are written
TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.
Sign up for our Weekly Sector Leaders Newsletter
11 sector-leading stocks delivered to your inbox every Sunday. Free.
No spam. Unsubscribe anytime.